Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients.

Amir GhaderiHamid Reza BanafsheNaghmeh MirhosseiniMohamad MoradiMohammad-Amin KarimiFateme MehrzadFereshteh BahmaniZatollah Asemi

Published in: BMC psychiatry (2019)

This study was retrospectively registered in the Iranian website ( www.irct.ir ) for clinical trials registration ( http://www.irct.ir : IRCT2017072333551N2). 07-31-2017 2.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
chronic kidney disease
bipolar disorder
prognostic factors
randomized controlled trial
phase ii
open label
placebo controlled